Nopal feeding reduces adiposity, intestinal inflammation and shifts the cecal microbiota and metabolism in high-fat fed rats

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Moran Ramos, Sofia ^a,b   He, Xuan ^c   Chin, Elizabeth L ^c   Tovar, Armando R ^a   Torres, Nimbe ^a   Slupsky, Carolyn M ^c   Raybould, Helen E ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Unidad Durango   (Mexico)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BETAINE; CELLULOSE; CHOLESTEROL; CHOLINE; GLUCOSE; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; MYELOPEROXIDASE; NOPAL; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; TRIMETHYLAMINE; GLUCOSE BLOOD LEVEL; PLANT MEDICINAL PRODUCT;

ABSORPTION; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CECUM; CELL SIZE; COMMUNITY STRUCTURE; CONTROLLED STUDY; DIETARY FIBER; DNA EXTRACTION; ENTERITIS; ENZYME ACTIVITY; GENE EXPRESSION; HISTOLOGY; INTESTINE FLORA; LIPID DIET; MALE; METABOLISM; METABOLOME; METABOLOMICS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; ADMINISTRATION AND DOSAGE; ANIMAL; ANIMAL FOOD; BLOOD; CACTACEAE; CHEMISTRY; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; INTESTINE; LIVER; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ADIPOSITY; ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; CACTACEAE; CECUM; DIET, HIGH-FAT; DIETARY FIBER; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; INFLAMMATION; INTERLEUKIN-6; INTESTINES; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; PLANT PREPARATIONS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 85012273648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0171672     Document Type: Article

References (61)

1. Frati-Munari AC, Fernandez-Harp JA, Banales-Ham M, Ariza-Andraca CR. Decreased blood glucose and insulin by nopal (Opuntia sp.). Arch Invest Med (Mex). 1983; 14(3):269-74. Epub 1983/01/01.
2. Frati-Munari AC, Fernandez-Harp JA, de la Riva H, Ariza-Andraca R, del Carmen Torres M. Effects of nopal (Opuntia sp.) on serum lipids, glycemia and body weight. Arch Invest Med (Mex). 1983; 14 (2):117-25. Epub 1983/04/01.
3. Moran-Ramos S, Avila-Nava A, Tovar AR, Pedraza-Chaverri J, Lopez-Romero P, Torres N. Opuntia ficus indica (nopal) attenuates hepatic steatosis and oxidative stress in obese Zucker (fa/fa) rats. J Nutr. 2012; 142(11):1956-63. Epub 2012/09/28. doi: 10.3945/jn.112.165563 PMID: 23014486
4. Guevara-Cruz M, Tovar AR, Aguilar-Salinas CA, Medina-Vera I, Gil-Zenteno L, Hernandez-Viveros I, et al. A dietary pattern including nopal, chia seed, soy protein, and oat reduces serum triglycerides and glucose intolerance in patients with metabolic syndrome. J Nutr. 2012; 142(1):64-9. Epub 2011/11/18. doi: 10.3945/jn.111.147447 PMID: 22090467
5. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring). 2007; 15(4):798-808. Epub 2007/04/12.
6. Bielohuby M, Sisley S, Sandoval D, Herbach N, Zengin A, Fischereder M, et al. Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am J Physiol Endocrinol Metab. 2013; 305(9):E1059-70. Epub 2013/08/29. doi: 10.1152/ajpendo.00208.2013 PMID: 23982154
7. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2):85-97. Epub 2011/01/22. doi: 10.1038/nri2921 PMID: 21252989
8. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat dietinduced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010; 299(2):G440-8. Epub 2010/05/29. doi: 10.1152/ajpgi.00098.2010 PMID: 20508158
9. Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 2012; 7(10):e47713. Epub 2012/10/24. doi: 10.1371/journal.pone.0047713 PMID: 23091640
10. Erdelyi I, Levenkova N, Lin EY, Pinto JT, Lipkin M, Quimby FW, et al. Western-style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer. J Nutr. 2009; 139(11):2072-8. Epub 2009/09/18. doi: 10.3945/jn.108.104125 PMID: 19759248
11. Qiao Y, Sun J, Ding Y, Le G, Shi Y. Alterations of the gut microbiota in high-fat diet mice is strongly linked to oxidative stress. Appl Microbiol Biotechnol. 2013; 97(4):1689-97. Epub 2012/09/06. doi: 10. 1007/s00253-012-4323-6 PMID: 22948953
12. Kaliannan K, Hamarneh SR, Economopoulos KP, Nasrin Alam S, Moaven O, Patel P, et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A. 2013; 110 (17):7003-8. Epub 2013/04/10. doi: 10.1073/pnas.1220180110 PMID: 23569246
13. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 2010; 5(8):e12191. Epub 2010/09/03. doi: 10.1371/journal.pone.0012191 PMID: 20808947
14. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009; 58(8):1091-103. Epub 2009/02/26. doi: 10.1136/gut.2008.165886 PMID: 19240062
15. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. Epub 2008/02/29. doi: 10.2337/db07-1403 PMID: 18305141
16. Chen HC, Farese RV, Jr. Determination of adipocyte size by computer image analysis. J Lipid Res. 2002; 43(6):986-9. Epub 2002/05/29. PMID: 12032175
17. Orozco-Ibarra M, Medina-Campos ON, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Floriano-Sanchez E, Santamaria A, et al. Evaluation of oxidative stress in D-serine induced nephrotoxicity. Toxicology. 2007; 229(1-2):123-35. Epub 2006/11/18. doi: 10.1016/j.tox.2006.10.008 PMID: 17110013
18. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. Epub 2001/05/09. PMID: 11328886
19. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226(1):497-509. Epub 1957/05/01. PMID: 13428781
20. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. Epub 1959/08/01. doi: 10.1139/o59-099 PMID: 13671378
21. O'Sullivan A, He X, McNiven EM, Haggarty NW, Lonnerdal B, Slupsky CM. Early diet impacts infant rhesus gut microbiome, immunity, and metabolism. J Proteome Res. 2013; 12(6):2833-45. Epub 2013/05/ 09. doi: 10.1021/pr4001702 PMID: 23651394
22. Slisz AM, Breksa AP 3rd, Mishchuk DO, McCollum G, Slupsky CM. Metabolomic analysis of citrus infection by 'Candidatus Liberibacter' reveals insight into pathogenicity. J Proteome Res. 2012; 11 (8):4223-30. Epub 2012/06/16. doi: 10.1021/pr300350x PMID: 22698301
23. O'Sullivan A, He X, McNiven EMS, Haggarty NW, Lonnerdal B, Slupsky CM. Early diet impacts infant rhesus gut microbiome, immunity, and metabolism. J Proteome Res. 2013; 12(6):2833-45. doi: 10. 1021/pr4001702 PMID: 23651394
24. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011; 12(6):R60. Epub 2011/06/28. PubMed Central PMCID: PMCPMC3218848. doi: 10.1186/gb-2011-12-6-r60 PMID: 21702898
25. Feugang JM, Konarski P, Zou D, Stintzing FC, Zou C. Nutritional and medicinal use of Cactus pear (Opuntia spp.) cladodes and fruits. Front Biosci. 2006; 11:2574-89. Epub 2006/05/25. PMID: 16720335
26. Matsuzawa T, Hayashi Y, Nomura M, Unno T, Igarashi T, Furuya T, et al. A survey of the values of clinical chemistry parameters obtained for a common rat blood sample in ninety-eight Japanese laboratories. J Toxicol Sci. 1997; 22(1):25-44. Epub 1997/02/01. PMID: 9076655
27. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12):1796-808. Epub 2003/ 12/18. doi: 10.1172/JCI19246 PMID: 14679176
28. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis. 2001; 21(1):89-104. Epub 2001/04/ 12. PMID: 11296700
29. Kathirvel E, Morgan K, Nandgiri G, Sandoval BC, Caudill MA, Bottiglieri T, et al. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol. 2010; 299(5):G1068-77. Epub 2010/08/21. doi: 10.1152/ajpgi.00249.2010 PMID: 20724529
30. Wang Z, Yao T, Pini M, Zhou Z, Fantuzzi G, Song Z. Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2010; 298(5):G634-42. Epub 2010/03/06. doi: 10.1152/ajpgi. 00249.2009 PMID: 20203061
31. Olthof MR, Hollman PC, Buijsman MN, van Amelsvoort JM, Katan MB. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr. 2003; 133(6):1806-14. PMID: 12771321
32. Moco S, Martin F-P, Rezzi S. A metabolomics view on gut microbiome modulation by polyphenol-rich foods. J Proteome Res. 2012; 11:4781-90. doi: 10.1021/pr300581s PMID: 22905879
33. Tzounis X, Vulevic J, Kuhnle GGC, George T, Leonczak J, Gibson GR, et al. Flavanol monomerinduced changes to the human faecal microflora. Br J Nutr. 2008; 99(4):782-92. doi: 10.1017/ S0007114507853384 PMID: 17977475
34. Alarcon-Aguilar FJ, Valdes-Arzate A, Xolalpa-Molina S, Banderas-Dorantes T, Jimenez-Estrada M, Hernandez-Galicia E, et al. Hypoglycemic activity of two polysaccharides isolated from Opuntia ficusindica and O. streptacantha. Proc West Pharmacol Soc. 2003; 46:139-42. Epub 2004/01/01. PMID: 14699912
35. Luo CA, Zhang WN, Sheng CQ, Zheng CJ, Yao JZ, Miao ZY. Chemical Composition and Antidiabetic Activity of Opuntia Milpa Alta Extracts. Chemistry & Biodiversity. 2010; 7(12):2869-79.
36. Coenen KR, Gruen ML, Chait A, Hasty AH. Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes. 2007; 56(3):564-73. Epub 2007/ 03/01. doi: 10.2337/db06-1375 PMID: 17327423
37. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest. 1998; 101(6):1354-61. Epub 1998/04/29. doi: 10.1172/JCI1235 PMID: 9502777
38. Craig SA. Betaine in human nutrition. Am J Clin Nutr. 2004; 80(3):539-49. Epub 2004/08/24. PMID: 15321791
39. Chen YM, Liu Y, Zhou RF, Chen XL, Wang C, Tan XY, et al. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. Sci Rep. 2016; 6:19076. PubMed Central PMCID: PMC4705470. doi: 10.1038/srep19076 PMID: 26743949
40. Wang L, Chen L, Tan Y, Wei J, Chang Y, Jin T, et al. Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein E deficient mice via reducing methylation of peroxisomal proliferatoractivated receptor alpha promoter. Lipids Health Dis. 2013; 12:34. doi: 10.1186/1476-511X-12-34 PMID: 23497035
41. Serkova NJ, Jackman M, Brown JL, Liu T, Hirose R, Roberts JP, et al. Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol. 2006; 44(5):956-62. Epub 2005/10/15. doi: 10.1016/j.jhep. 2005.07.009 PMID: 16223541
42. Ye JH, Rajendran VM. Adenosine: An immune modulator of inflammatory bowel diseases. World J Gastroenterol. 2009; 15:4491-8. doi: 10.3748/wjg.15.4491 PMID: 19777607
43. Neyrinck AM, Bindels LB, De Backer F, Pachikian BD, Cani PD, Delzenne NM. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int Immunopharmacol. 2009; 9(6):767-73. Epub 2009/ 03/17. doi: 10.1016/j.intimp.2009.02.015 PMID: 19286482
44. Neyrinck AM, Possemiers S, Verstraete W, De Backer F, Cani PD, Delzenne NM. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem. 2012; 23(1):51-9. Epub 2011/03/18. doi: 10.1016/j.jnutbio.2010.10.008 PMID: 21411304
45. Neyrinck AM, Possemiers S, Druart C, Van de Wiele T, De Backer F, Cani PD, et al. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One. 2011; 6(6):e20944. Epub 2011/06/23. doi: 10.1371/journal.pone. 0020944 PMID: 21695273
46. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014; 40(1):128-39. doi: 10.1016/j.immuni.2013.12.007 PMID: 24412617
47. Lee WJ, Hase K. Gut microbiota-generated metabolites in animal health and disease. Nat Chem Biol. 2014; 10(6):416-24. Epub 2014/05/20. doi: 10.1038/nchembio.1535 PMID: 24838170
48. Torres N, Guevara-Cruz M, Velazquez-Villegas LA, Tovar AR. Nutrition and atherosclerosis. Arch Med Res. 2015; 46:408-26. doi: 10.1016/j.arcmed.2015.05.010 PMID: 26031780
49. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008; 3(4):213-23. Epub 2008/04/ 15. PubMed Central PMCID: PMCPMC3687783. doi: 10.1016/j.chom.2008.02.015 PMID: 18407065
50. Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014; 146(6):1500-12. Epub 2014/03/04. PubMed Central PMCID: PMCPMC4114504. doi: 10.1053/j.gastro.2014.02.037 PMID: 24583088
51. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500(7464):541-6. Epub 2013/08/30. doi: 10. 1038/nature12506 PMID: 23985870
52. Kim A. Dysbiosis: A Review Highlighting Obesity and Inflammatory Bowel Disease. J Clin Gastroenterol. 2015; 49 Suppl 1:S20-4. Epub 2015/10/09.
53. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013; 500(7464):585-8. Epub 2013/08/30. doi: 10.1038/ nature12480 PMID: 23985875
54. Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013; 98(1):16-24. Epub 2013/05/31. doi: 10.3945/ajcn.113.058743 PMID: 23719559
55. Zhang C, Zhang M, Pang X, Zhao Y, Wang L, Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012; 6(10):1848-57. Epub 2012/04/13. PubMed Central PMCID: PMCPMC3446802. doi: 10.1038/ismej.2012.27 PMID: 22495068
56. Pedersen R, Ingerslev HC, Sturek M, Alloosh M, Cirera S, Christoffersen BO, et al. Characterisation of gut microbiota in Ossabaw and Gottingen minipigs as models of obesity and metabolic syndrome. PLoS One. 2013; 8(2):e56612. Epub 2013/02/26. PubMed Central PMCID: PMCPMC3577853. doi: 10. 1371/journal.pone.0056612 PMID: 23437186
57. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014; 11(8):497-505. Epub 2014/04/23. doi: 10.1038/nrgastro.2014.40 PMID: 24751910
58. Zenewicz LA, Yin X, Wang G, Elinav E, Hao L, Zhao L, et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol. 2013; 190(10):5306-12. Epub 2013/04/16. PubMed Central PMCID: PMCPMC3646987. doi: 10.4049/jimmunol.1300016 PMID: 23585682
59. Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio. 2015; 6(2):e02481. Epub 2015/03/19. PubMed Central PMCID: PMCPMC4453578. doi: 10. 1128/mBio.02481-14 PMID: 25784704
60. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A. 2006; 103(33):12511-6. Epub 2006/08/10. PubMed Central PMCID: PMCPMC1567909. doi: 10.1073/ pnas.0601056103 PMID: 16895997
61. He X, Slupsky CM. Metabolic fingerprint of dimethyl sulfone (DMSO2 ) in microbial-mammalian cometabolism. J Proteome Res. 2014; 13:5281-92. doi: 10.1021/pr500629t PMID: 25245235